Pfizer has voluntarily initiated a Class II recall for  220,761 bottles of the antidepressant Pristiq (desvenlafaxine) extended-release tablets 50 mg, 30 count bottle, prescription because a single Pristiq 100-mg tablet was found in a bottle of 50-mg Pristiq. The recall, which was initiated on April 16, 2014, was reported in the weekly Enforcement Report of the US Food and Drug Administration (FDA) for July 2, 2014.

A Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Source: FDA